NIAID Awards Paragon Bioservices a Multiple Award IDIQ Contract valued up to $159M for Preclinical Drug Development Services

NewSpring Healthcare

This article first appeared on PR Newswire on January 17th, 2017.

BALTIMORE, Jan. 17, 2017 /PRNewswire/ — Paragon Bioservices received a multiple-award, indefinite-delivery, indefinite-quantity (IDIQ) contract to provide product development services for a variety of National Institute of Allergy and Infectious Diseases (NIAID) medical product development activities. The IDIQ mechanism will allow Paragon to compete within a contractor pool for task order awards up to $159 million.  Read more...